Literature DB >> 20847246

Public health. No vaccines in the time of cholera.

Martin Enserink.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20847246     DOI： 10.1126/science.329.5998.1462

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

1.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

Review 2.  Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.

Authors:  Sachin N Desai; Alejandro Cravioto; Dipika Sur; Suman Kanungo
Journal:  Hum Vaccin Immunother       Date:  2014-05-26       Impact factor: 3.452

3.  NhaP1 is a K+(Na+)/H+ antiporter required for growth and internal pH homeostasis of Vibrio cholerae at low extracellular pH.

Authors:  Matthew J Quinn; Craig T Resch; Jonathan Sun; Erin J Lind; Pavel Dibrov; Claudia C Häse
Journal:  Microbiology       Date:  2012-01-12       Impact factor: 2.777

4.  The origin of the Haitian cholera outbreak strain.

Authors:  Chen-Shan Chin; Jon Sorenson; Jason B Harris; William P Robins; Richelle C Charles; Roger R Jean-Charles; James Bullard; Dale R Webster; Andrew Kasarskis; Paul Peluso; Ellen E Paxinos; Yoshiharu Yamaichi; Stephen B Calderwood; John J Mekalanos; Eric E Schadt; Matthew K Waldor
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

Review 5.  Plant-made vaccines in support of the Millennium Development Goals.

Authors:  Claire A Penney; David R Thomas; Sadia S Deen; Amanda M Walmsley
Journal:  Plant Cell Rep       Date:  2011-01-18       Impact factor: 4.570

6.  Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.

Authors:  Kashmira A Date; Andrea Vicari; Terri B Hyde; Eric Mintz; M Carolina Danovaro-Holliday; Ariel Henry; Jordan W Tappero; Thierry H Roels; Joseph Abrams; Brenton T Burkholder; Cuauhtémoc Ruiz-Matus; Jon Andrus; Vance Dietz
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883

7.  Evaluation and use of surveillance system data toward the identification of high-risk areas for potential cholera vaccination: a case study from Niger.

Authors:  Jose Guerra; Bachir Mayana; Ali Djibo; Mahamane L Manzo; Augusto E Llosa; Rebecca F Grais
Journal:  BMC Res Notes       Date:  2012-05-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.